Evolus Inc
NASDAQ:EOLS

Watchlist Manager
Evolus Inc Logo
Evolus Inc
NASDAQ:EOLS
Watchlist
Price: 9.73 USD -0.71% Market Closed
Market Cap: 627.3m USD

Wall Street
Price Targets

EOLS Price Targets Summary
Evolus Inc

Wall Street analysts forecast EOLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EOLS is 23.46 USD with a low forecast of 20.2 USD and a high forecast of 26.25 USD.

Lowest
Price Target
20.2 USD
108% Upside
Average
Price Target
23.46 USD
141% Upside
Highest
Price Target
26.25 USD
170% Upside
Evolus Inc Competitors:
Price Targets
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
1% Upside
512
Grand Pharmaceutical Group Ltd
3% Upside
AGY
Allergy Therapeutics PLC
95% Upside
HIKAL
Hikal Ltd
31% Upside
033270
Korea United Pharm Inc
37% Upside
053030
Binex Co Ltd
91% Upside

Revenue
Forecast

Revenue Estimate
Evolus Inc

The compound annual growth rate of Evolus Inc's revenue for the next 3 years is 31%.

N/A
Past Growth
31%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Evolus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat

Net Income
Forecast

Net Income Estimate
Evolus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EOLS's stock price target?
Price Target
23.46 USD

According to Wall Street analysts, the average 1-year price target for EOLS is 23.46 USD with a low forecast of 20.2 USD and a high forecast of 26.25 USD.

What is Evolus Inc's Revenue forecast?
Projected CAGR
31%

The compound annual growth rate of Evolus Inc's revenue for the next 3 years is 31%.

Back to Top